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Impact of Ambulatory Blood Pressure on Early Cardiac 
and Renal Dysfunction in Hypertensive Patients  
without Clinically Apparent Target Organ Damage
Darae Kim, Chi Young Shim, Geu-Ru Hong, Sungha Park, In Jeong Cho,  
Hyuk-Jae Chang, Jong-Won Ha, and Namsik Chung
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea. 
Purpose: Impaired left ventricular (LV) global longitudinal strain (GLS) and the presence of microalbuminuria indicate early car-
diac and renal dysfunction. We aimed to determine the relationships among 24-h ambulatory blood pressure (BP) variables, LV 
GLS, and urine albumin creatinine ratio (UACR) in hypertensive patients.
Materials and Methods: A total of 130 hypertensive patients (mean age 53 years; 59 men) underwent 24-h ambulatory BP moni-
toring, measurements of peripheral and central BPs, and transthoracic echocardiography. Patients with apparent LV systolic dys-
function (LV ejection fraction <50%) or chronic kidney disease were not included. LV GLS was calculated using two-dimensional 
speckle tracking, and UACR was analyzed from spot urine samples.
Results: In simple correlation analysis, LV GLS showed the most significant correlation with mean daytime diastolic BP (DBP) 
(r=0.427, p<0.001) among the various BP variables analyzed. UACR revealed a significant correlation only with night-time mean 
systolic BP (SBP) (r=0.253, p=0.019). In multiple regression analysis, daytime mean DBP and night-time mean SBP were indepen-
dent determinants for LV GLS (β=0.35, p=0.028) and log UACR (β=0.49, p=0.007), respectively, after controlling for confounding 
factors. Daytime mean DBP showed better diagnostic performance for impaired LV GLS than did peripheral or central DBPs, 
which were not diagnostic. Night-time mean SBP showed satisfactory diagnostic performance for microalbuminuria.
Conclusion: There are different associations for daytime and night-time BP with early cardiac and renal dysfunction. Ambulatory 
BP monitoring provides more relevant BP parameters than do peripheral or central BPs regarding early cardiac and renal dys-
function in hypertensive patients.
Key Words: Ambulatory blood pressure monitoring, global longitudinal strain, microalbuminuria
INTRODUCTION
The presence of target organ damage in hypertensive patients 
is a risk factor for major cardiovascular events.1,2 Early detec-
tion of subclinical target organ dysfunction allows clinicians 
to prevent progression to target organ damage. Previous stud-
ies have suggested that ambulatory blood pressures (BPs) 
predict future cardiovascular events better than office periph-
eral BPs.3,4 Although many studies have demonstrated that 
ambulatory BP variables are associated with subclinical struc-
tural or functional changes in the heart and kidneys in various 
hypertensive populations,5-7 the data regarding the associa-
tion between daytime or night-time BPs and cardiac or renal 
damage are discrepant and inconclusive. Furthermore, cardiac 
and renal damage may not occur in parallel in each individual 
with mild hypertension.8
Most previous studies have used the presence of left ven-
tricular hypertrophy (LVH) or increased left ventricular (LV) 
mass index as a surrogate indicator for target organ damage to 
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the heart.9 Recently, LV global longitudinal strain (GLS) was 
shown to be a sensitive marker of subclinical LV dysfunction, 
and the independent prognostic implications of LV GLS have 
been verified in various cardiovascular diseases, including hy-
pertension.10-12 Microalbuminuria is known as an early marker 
of target organ damage in hypertension.13 Accordingly, in this 
study, we tested the hypotheses that 1) ambulatory BP variables 
would better correlate with LV GLS than would peripheral or 
central BPs and that the associations would be significant 
even in patients without LVH, that 2) ambulatory BP variables 
would better correlate with degrees of microalbuminuria than 
would peripheral or central BPs, and that 3) associations be-
tween ambulatory BP variables and early cardiac or renal dys-
function would differ in hypertensive patients without clinically 
apparent target organ damage. 
 
MATERIALS AND METHODS
Study population
This cross-sectional study included 130 patients with at least a 
3-month history of uncomplicated arterial hypertension, ac-
cording to current guidelines.14 Patients were enrolled from 
the outpatient clinic of a single tertiary center from March 2011 
to December 2015. At initial enrollment, a complete clinical 
examination was performed to exclude secondary causes of 
hypertension. Past medical histories, including current hyper-
tensive medications, were reviewed through electronic medi-
cal records. Exclusion criteria included diabetes mellitus, sig-
nificant valvular disease (≥moderate severity), apparent LV 
systolic dysfunction (ejection fraction <50%), chronic kidney 
disease [estimated glomerular filtration rate (eGFR) <60 mL/
min/1.73 m2], hypertrophic cardiomyopathy, previous history 
of stroke, previous history of myocardial infarction, unstable 
angina, atrial fibrillation, life threatening arrhythmia, second-
ary hypertensive disease, or neoplastic disease. Smokers were 
defined as current smokers. 
Comprehensive cardiovascular assessment, including elec-
trocardiogram, transthoracic echocardiography, 24-h ambu-
latory BP monitoring, measurements of peripheral and central 
BPs, and laboratory assessment, including fasting glucose, lipid 
profile, blood urea nitrogen, creatinine, and urine albumin cre-
atinine ratio (UACR), was performed at initial enrollment. Writ-
ten informed consent was obtained from all patients. The proto-
col was approved by our Institutional Review Board (IRB No. 
2017-1681-001).
Assessments of peripheral, central, and 24-h 
ambulatory BPs
Peripheral systolic BP (SBP) and diastolic BP (DBP) measure-
ments were performed automatically (Omron M4 Plus, Omron 
Healthcare Co. Ltd., Kyoto, Japan) at the brachial artery of the 
non-dominant arm in a relaxed seated position. Two BP mea-
surements obtained at an interval of 5 minutes during the same 
visit were performed and averaged. Central SBP, DBP, and pulse 
pressure (PP) were assessed with pulse wave analysis of the ra-
dial artery using commercially available radial artery tonome-
try (SphygmoCor, AtCor Medical, Sydney, Australia).15,16
Ambulatory BP monitoring was performed with an appro-
priately sized BP cuff on the non-dominant arm using a BP 
monitor (Model 90207; Spacelabs Healthcare; Snoqualmie, WA, 
USA) programmed to record the BP every 1 hour throughout 
a 24-h period. Patients were instructed to note the times of go-
ing to bed in the evening and waking up in the morning to 
calculate mean daytime and night-time BPs. Night-time BP 
was defined as the BPs from the time when the patient went 
to bed until the time he or she got out of bed, and daytime BP 
was defined as the BPs recorded during the rest of the day. 
Mean 24-h BP was calculated as the mean of all the readings 
throughout the 24-h period. The morning BP surge was calcu-
lated as follows: morning SBP–lowest night-time SBP.17 Noc-
turnal hypertension was defined as night-time mean SBP ≥120 
mm Hg or DBP ≥70 mm Hg. 
Two-dimensional, Doppler, and speckle tracking 
echocardiography 
Each patient underwent a comprehensive transthoracic echo-
cardiographic study using a Vivid 7 or Vivid 9 cardiovascular 
ultrasound system (GE Medical Systems, Horten, Norway) 
equipped with 2.5−3.5 MHz phased-array sector probes. Stan-
dard two-dimensional (2D) and Doppler measurements were 
performed per the recommendations of the American Society 
of Echocardiography guidelines.18 LVH was diagnosed accord-
ing to the American Society of Echocardiography recommend-
ed formula for estimation of the LV mass index and indexed to 
body surface area (cutoff values for men LV mass index >115 g/m2 
and for women >95 g/m2). From the apical window, mitral in-
flow velocities were traced, and the following variables were 
obtained: peak velocity of early diastolic mitral inflow (E), late 
diastolic mitral inflow (A), and deceleration time of the E ve-
locity. Early diastolic mitral annular velocity (e’), late diastolic 
mitral annular velocity, and systolic mitral annular velocity (S’) 
were measured from the apical four-chamber view with a 2- 
to 5-mm sample volume placed at the septal corner of the mi-
tral annulus. 
Each patient underwent 2D-speckle echocardiography of 
the LV. Three consecutive cardiac cycles were recorded and av-
eraged, and the frame rates were set to 60–80 frames/sec. LV 
GLS was measured by averaging all regional peak longitudinal 
strains from three apical views (apical 4-, 2-, and 3-chamber 
views). Standard deviations (SDs) of time to peak longitudinal 
strain (LS) from all segments were analyzed (SD of time to peak 
LS). LV global circumferential strain (GCS) was obtained from 
averaging all circumferential strains from short axis views of 
the mitral valve, papillary muscle, and LV apex level. The analy-
sis was performed offline using customized software (EchoPAC 
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PC, version 113; GE Medical Systems). 
Definition of early cardiac or renal dysfunction 
Early cardiac or renal dysfunction was defined by the presence 
of abnormal LV GLS or the presence of microalbuminuria, re-
spectively. The presence of microalbuminuria was assessed 
by gender-specific UACR cut-off values (≥17 mg/g in men and 
≥25 mg/g in women).19 Abnormal LV GLS was defined as a 
GLS absolute value less than 20% in accordance with current 
guidelines.20 
Statistical analysis 
Continuous variables are presented as means±SD, and categori-
cal variables are presented as a percentage. Spearman’s sim-
ple correlation analyses were performed to assess correlations 
with 24-h ambulatory BP variables with log UACR or LV GLS. 
Multiple linear regressions were performed to assess indepen-
dent associations between LV GLS or log UACR with the 24-h 
ambulatory BP parameters, respectively. Covariates, includ-
ing age, gender, and other pertinent covariates, were selected 
based on their association with each parameter (the threshold 
for inclusion in the multivariable models was set at a p value of 
<0.2). The performance of the predictive selected parameters 
was assessed using the area under the receiver operating char-
acteristic (ROC) curve (AUC), and diagnostic performances 
were compared by means of Delong tests.21 A p-value <0.05 was 
regarded as statistically significant. Analyses were undertaken 
using SPSS 21.0 (IBM Corp., Armonk, NY, USA).
Reproducibility
Interobserver and intraobserver variabilities were examined 
for LV GLS and GCS using intraclass and interclass correlation 
coefficients. Intra-observer variability for LV GLS and GCS pa-
rameters was analyzed for a group of twenty randomly select-
ed subjects by one observed who repeated it twice. Inter-ob-
served variability was assessed with the same data sets by two 
investigators who were unaware of each other’s measurements. 
The intraobserver and interobserver interclass correlation co-
efficients were 0.97 [95% confidene interval (CI): 0.89−0.99] 
and 0.94 (95% CI: 0.29−0.98) for LV GLS and 0.94 (95% CI: 
0.84−0.98) and 0.90 (95% CI: 0.75−0.96) for the LV GCS, re-
spectively. 
RESULTS
Baseline characteristics
The mean age of the enrolled patients was 53±14 years and 59 
(45%) were men. The incidence of comorbidities is described 
in Table 1; none of the patients were diagnosed with diabetes 
mellitus, atrial fibrillation, previous myocardial infarction, or 
stroke. Only 24 (18%) were diagnosed with dyslipidemia. Twen-
ty-one patients (16%) had microalbuminuria and 33 (25%) 
Table 1. Baseline Characteristics of the Study Population
Baseline characteristics n=130
Age (yr)   53±14
Male gender, n (%)   59 (45)
Body mass index (kg/m2) 24.4±3.2
Dyslipidemia, n (%)   24 (18)
Smoking, n (%) 12 (9)
Target organ damage
Urine albumin/creatinine ratio 7.1 (0–13.2)
Presence of microalbuminuria, n (%)   21 (16)
LV mass index (g/m2)   91.8±19.6
Presence of LV hypertrophy, n (%)   33 (25)
Medications
RAAS blockers, n (%)   52 (40)
Beta blockers, n (%)   17 (13)
Calcium channel blockers, n (%)   32 (25)
Diuretics, n (%)   7 (5)
Statin, n (%)   24 (18)
Office peripheral BPs (mm Hg)
Peripheral SBP 146±17
Peripheral DBP   85±12
Peripheral PP   61±13
Office central BPs (mm Hg) 
Central SBP 134±17
Central DBP   86±13
Central PP   48±13
24-hour ambulatory BPs
24-hr mean SBP (mm Hg) 135±15
24-hr mean DBP (mm Hg)   84±10
Daytime mean SBP (mm Hg) 143±15
Daytime mean DBP (mm Hg)   88±11
Night-time mean SBP (mm Hg) 126±16
Night-time mean DBP (mm Hg)   77±11
Morning BP surge, n (%)   39 (30)
Nocturnal hypertension, n (%)   86 (66)
LV, left venticle; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, 
pulse pressure; RAAS, renin angiotensin aldosterone system; BP, blood pressure.
showed LVH as target organ damage. Fifty-nine patients (45%) 
were drug naïve hypertensive patients. The most prevalent hy-
pertensive medication was angiotensin-converting enzyme in-
hibitors or angiotensin receptor blockers in 52 patients (40%).
Echocardiographic characteristics of the patients are de-
scribed in Table 2. The mean LV mass index was 91.8±19.6 g/m2. 
The incidence of abnormal LV geometry was as follows: con-
centric LV remodeling in 11 (8.5%) patients, concentric LVH 
in 13 (10.0%) patients, and eccentric LVH in 20 (15.4%) patients. 
LV ejection fraction was within the normal range (68±6%); 
however, the mean value of LV GLS (-17.3±2.9 %) was not within 
the normal range.
Peripheral BP, central BP, and 24-h ambulatory BPs of patients 
revealed that the enrolled patients were mildly hypertensive 
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as described in Table 3. The mean value of peripheral SBP was 
146 mm Hg, while mean values of central SBP and 24-hr mean 
SBP were 134 mm Hg and 135 mm Hg, respectively. Thirty-nine 
(30%) patients revealed morning surges, and 86 patients (66%) 
met the criteria of nocturnal hypertension. 
Associations between blood pressure variables and 
early target organ dysfunction
In a simple correlation analysis, LV GLS was significantly as-
sociated with peripheral SBP, DBP, central SBP, DBP, and all 24-h 
ambulatory BP parameters, while LV mass index did not show 
any significant association with any of the BP parameters (Fig. 
1A and B, Table 3). Although the association of LV GLS with 
daytime mean DBP was significant in patients, regardless of 
the presence of LVH, the association was stronger in patients 
without LVH than in those with LVH (Fig. 1C and D). Log UACR 
showed a significant correlation only with night-time mean 
SBP (r=0.253, p=0.019) (Fig. 2, Table 3).
Multiple regression analysis revealed that LV GLS had an in-
dependent correlation with daytime mean DBP (β=0.35, p= 
0.028), even after adjustment for age, gender, usage of renin an-
giotensin aldosterone system (RAAS) blocker, LV mass index, 
LV ejection fraction, peripheral DBP, central DBP, and night-
time mean DBP (Table 4). Log UACR showed an independent 
correlation with night-time mean SBP (β=0.49, p=0.007), even 
after adjustment for age, gender, usage of RAAS blocker, eGFR, 
peripheral SBP, central SBP, and daytime mean SBP (Table 4).
As shown in Fig. 3A, diagnostic performances of peripheral 
DBP, central DBP, daytime mean DBP, and night-time mean 
DBP for abnormal LV GLS were all satisfactory (peripheral DBP, 
AUC=0.706, p=0.006; central DBP, AUC=0.701, p=0.007; day-
time mean DBP, AUC=0.803, p<0.001; night-time mean DBP, 
AUC=0.705, p=0.006). There was no significant difference 
among diagnostic performances of BP parameters for abnor-
mal LV GLS, while daytime mean DBP showed the largest 
AUC (AUC: 0.803, 95% CI: 0.711−0.896, p<0.001) among four BP 
parameters (Fig. 3A). Evaluation of diagnostic performances 
for microalbuminuria indicated that only night-time mean 
SBP had a significant p value (AUC: 0.700, 95% CI: 0.580− 
0.824, p=0.004), while peripheral SBP, central SBP, and day-
time mean SBP did not (Fig. 3B). 
DISCUSSION
The principal findings in the present study are that 1) daytime 
mean DBP correlated better with LV GLS than did peripheral 
or central BPs, regardless of the presence of LVH, that 2) night-
time mean SBP was the only parameter that showed a signifi-
cant correlation with the degree of microalbuminuria, and that 
3) associations between ambulatory BP variables and early 
cardiac or renal dysfunction differ in hypertensive patients 
without clinically apparent target organ damage. These data 
suggest that risk assessments using ambulatory BP variables 
Table 2. 2D, Doppler, and Speckle Tracking Echocardiography 
Echocardiographic parameters n=130
2D and Doppler echocardiography 
LV end-diastolic dimension (mm) 48±4
LV end-systolic dimension (mm) 32±4
IVS thickness (mm)   9.4±1.4
PW thickness (mm)   9.2±1.3
Relative wall thickness   0.38±0.52
LV mass index (g/m2)   91.8±19.6
LV ejection fraction (%) 68±6
e’ velocity (cm/sec)   7.1±2.5
S’ velocity (cm/sec)   7.5±1.6
E/e’   9.9±2.8
LA volume index (mL/m2) 26.7±7.0
2D speckle tracking imaging 
LV-GLS (%)  -17.3±2.9
SD of time to peak LS (msec)   47.9±15.0
LV-GCS (%)  -22.8±4.8
2D, two-dimensional; LV, left ventricle; IVS, interventricular septum; PW, pos-
terior wall; LA, left atrium; GLS, global longitudinal strain; GCS, global cir-
cumferential strain; SD, standard deviation; LS, longitudinal strain.
Table 3. Simple Correlations between Blood Pressures and Target Organ Dysfunction 
BP parameters
LV-GLS (%) Log UACR
R p value R p value
Peripheral SBP 0.251   0.006 -0.034 0.757
Peripheral DBP 0.359 <0.001  0.107 0.336
Central SBP 0.219   0.018  0.088 0.432
Central DBP 0.366 <0.001  0.064 0.565
24-hr mean SBP 0.302   0.001  0.107 0.325
24-hr mean DBP 0.418 <0.001  0.052 0.633
Daytime mean SBP 0.320 <0.001  0.051 0.640
Daytime mean DBP 0.427 <0.001 -0.008 0.942
Night-time mean SBP 0.241 <0.001  0.253 0.019
Night-time mean DBP 0.349 <0.001  0.204 0.060
LV, left ventricle; GLS, global longitudinal strain; UACR, urine albumin creatinine ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure.
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will be useful for the prediction of early cardiac and renal dys-
function.
Impact of daytime and night-time BP on subclinical 
target organ damage
Current guidelines recommend assessing target organ dam-
age in hypertensive patients, as they have independent prog-
nostic significance and are associated with an increased car-
diovascular mortality of >20% within 10 years.1,22 Previous 
studies showed that subclinical target organ damage, such as 
LVH as detected by echocardiography or microalbuminuria, 
are reliable cardiovascular risk predictors.23-25 Subclinical LV 
dysfunction presenting with reduced LV GLS in hypertensive 
patients has been recently recognized.26-29 Saito, et al.26 report-
ed that reduced LV GLS is independently associated with ma-
jor adverse cardiovascular events. Therefore, patients with 
subclinical target organ damage are at high risk and should be 
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treated more meticulously. A recent study reported that me-
chanical abnormalities of the LV in hypertensive patients with 
normal ejection fraction could be improved by targeted anti-
hypertensive treatment.30 These findings suggest the impor-
tance of using adequate therapeutic monitoring parameters 
for subclinical target organ damage that may lead to improved 
clinical prognoses.
Impact of daytime blood pressure on subclinical 
cardiac dysfunction
From the multivariate analysis in our study, daytime mean DBP 
was shown to be significantly associated with abnormal LV 
GLS, even after adjustment for age, gender, and peripheral and 
central BP parameters. From a simple correlation analysis, 
peripheral SBP and DBP showed significant correlations with 
LV GLS; however, daytime mean SBP and mean DBP showed 
stronger correlations. It is interesting that daytime mean DBP 
was independently associated with LV GLS, whereas daytime 
mean SBP showed less of an association. A previous study sug-
gested a different clinical implication of ambulatory BP accord-
ing to age, in which, in patients aged <60 years, ambulatory DBP 
provided significant incremental value for predicting a morbid 
cardiovascular event, whereas in patients aged >60 years, am-
bulatory PP was the best predictor of adverse events.31 In a 
Framingham study, DBP was the best predictor of coronary 
heart disease risk in men aged <45 years.32 Therefore, we be-
lieve the emphasis on daytime mean DBP over SBP should be 
interpreted with consideration of the mean age of our cohort. 
A progressive rise in both SBP and DBP in middle-aged popu-
lations correlates with the predominance of increased periph-
eral resistance, while increased PP due to a continued rise in 
SBP with a fall or plateau in DBP in older adults is associated 
with a predominance of arterial stiffness.33 Therefore, when 
monitoring early hypertensive patients at a relatively young 
age, DBP should be considered, as it reflects the main patho-
Table 4. Determinants for Early Cardiac and Renal Dysfunction
Variables β t p value
LV-GLS (R2=0.601)
Age 0.18 1.93 0.056
Female gender -0.21 -2.41 0.018
RAAS blocker 0.07 0.82 0.415
LV mass index 0.02 0.24 0.815
LV ejection fraction -0.36 -4.24 <0.001
Peripheral DBP -0.35 -0.92 0.360
Central DBP 0.40 1.09 0.280
Daytime mean DBP 0.35 2.23 0.028
Nigh-time mean DBP -0.05 -0.38 0.702
Log UACR (R2=0.491)
Age 0.12 0.97 0.337
Female gender 0.19 1.81 0.075
RAAS blocker -0.04 -0.38 0.705
eGFR -0.16 -1.59 0.142
Peripheral SBP 0.14 0.64 0.522
Central SBP -0.22 -1.09 0.279
Daytime mean SBP -0.23 -1.22 0.225
Night-time mean SBP 0.49 2.77 0.007
LV, left ventricle; GLS, global longitudinal strain; UACR, urine albumin creatinine 
ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimat-
ed glomerular filtration rate; RAAS, renin angiotensin aldosterone system.
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physiology of hypertension in this age range. In addition, day-
time mean DBP may better reflect peripheral resistance than 
mean SBP because it was steadier than SBP when the subjects 
engaged in daily activities. 
A previous study by Sera, et al.34 reported stronger associa-
tions between impaired LV GLS and ambulatory BP parame-
ters, compared to office BP parameters, in older adult patients. 
Our results also showed stronger correlation between abnor-
mal LV GLS and ambulatory BP parameter than peripheral or 
central BP parameters. Also, our study population comprised 
younger hypertensive patients with a relatively low burden of 
comorbidity, compared to previous studies; therefore, con-
founding factors that could affect LV GLS were limited. There-
fore, our results may strengthen previous studies by showing 
similar results in different populations and including central 
BP. Interestingly, the association with daytime BP and LV GLS 
was more significant in patients without LVH than in those 
with LVH (Fig. 1), suggesting that functional changes in the LV 
occur before structural changes of the LV and well reflects ar-
terial loads. This finding demonstrates that LV GLS could be used 
for risk stratification of mild hypertensive patients without clini-
cally significant target organ damage.
Impact of night-time blood pressure on subclinical 
renal dysfunction
Night time mean SBP showed better diagnostic power for the 
presence of microalbuminuria, compared to the peripheral, 
central, and daytime BP parameters. Previous studies have ad-
dressed the predictive role of night-time BP in comparison with 
daytime BP in different populations of hypertensive patients;35,36 
however, one study presented contrary results.31 Our data sup-
ports a significant association of night-time mean SBP with 
subclinical renal damage in mild asymptomatic hypertensive 
patients. In this study, the superiority of night-time mean SBP 
for predicting UACRs over other BP parameters was demon-
strated without using arbitrary dichotomous BP-related vari-
ables. The possible mechanism for the significant association 
of night-time BP and the presence of microalbuminuria could 
be explained by a blunted nocturnal BP fall from an imbalance 
of the autonomic nervous system favoring sympathetic over-ac-
tivity, altered baroreceptor sensitivity, or nocturnal volume over-
load needing higher night-time BP to sustain natriuresis.37,38 
Study limitation
There are some limitations to this study. First, because of the 
cross-sectional nature of our study, we cannot distinguish cause 
from effect. Second, patients enrolled in this study were select-
ed from a population with mild hypertension without comor-
bidities, including diabetes mellitus, atrial fibrillations, or cor-
onary artery diseases. However, a lack of confounding comor-
bidities was beneficial when analyzing LV mechanics in this 
population with limited confounding factors. Third, we assessed 
soft endpoints for the presence of subclinical target organ dam-
age; therefore, our results cannot be extrapolated for the inci-
dence of hard cardiovascular endpoints. However, given that 
subclinical target organ damage is a significant risk factor for 
hard cardiovascular outcomes, treating asymptomatic patients 
with mild hypertension with risk stratifications based on as-
sociated subclinical target organ damage may be an effective 
strategy for reducing future cardiovascular events. 
In conclusion, daytime mean DBP showed a significant as-
sociation with LV GLS regardless of the presence of LVH. Night-
time mean SBP better correlated with microalbuminuria than 
did peripheral or central BP in patients with mild hypertension. 
Ambulatory BP presented stronger associations with early 
cardiac and renal dysfunction than did peripheral or central 
BP, even in mild hypertensive patients without clinically ap-
parent target organ damage. Therefore, assessment of ambu-
latory BP in mild hypertensive patients may help to guide BP-
lowering treatment earlier and contribute to a reduction of 
future cardiovascular outcomes in the long term. 
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